Submit CT data of Liraglutide pre-filled pen for type 2 DM: CDSCO Panel Tells Biocon Pharma Dr. Divya Colin3 Aug 2024 6:00 PM ISTNew Delhi: Citing that the approved indication for BIOLIDE synthetic Liraglutide 6mg/ml solution for injection in a pre-filled pen in UK-MHRA is for...
Akums Drugs and Pharma Gets CDSCO Panel Nod to study Aceclofenac plus Drotaverine Hydrochloride tablet Dr. Divya Colin2 Aug 2024 6:00 PM ISTNew Delhi: The drug major Akums Drugs and Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the Central Drug...
Eli Lilly Gets CDSCO Panel Nod to Study Retatrutide Dr. Divya Colin1 Aug 2024 6:00 PM ISTNew Delhi: Pharmaceutical major Eli Lilly has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Insufficient CT data in female population: CDSCO Panel tells Alkem Laboratories on Relugolix Tablets Dr. Divya Colin31 July 2024 6:00 PM ISTNew Delhi: Noting insufficient clinical trial data in the female population for applied indication, the Subject Expert Committee (SEC) functional...
Akums Drugs and Pharmaceuticals Gets CDSCO Panel Nod To study Norethindrone, Estradiol, Relugolix FDC Dr. Divya Colin30 July 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has granted approval to the drug...
Drug Safety Alert: Indian Pharmacopoeia Commission Flags ADR Linked To Vancomycin Susmita Roy29 July 2024 6:00 PM ISTNew Delhi: The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of July, has revealed that...
Novartis Healthcare Gets CDSCO Panel Nod to Study Asciminib Filmcoated Tablets Dr. Divya Colin28 July 2024 6:00 PM ISTNew Delhi: Suggesting to add more government sites, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization...
Zydus Life Sciences Gets CDSCO Panel Nod to Study anti-cancer drug Relugolix Dr. Divya Colin27 July 2024 6:00 PM ISTNew Delhi: The drug major Zydus Lifscience has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
GSK Pharma India Gets CDSCO Panel Nod for phase 3 CT of Belrestotug and Dostarlimab Dr. Divya Colin26 July 2024 6:00 PM ISTNew Delhi: The drug major GSK Pharma India has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Submit AE and SAE Data : CDSCO Panel Tells MSN Pharmaceuticals on Anti-cancer Drug MK-1084 Dr. Divya Colin25 July 2024 6:00 PM ISTNew Delhi: Reviewing phase 3 clinical study protocol of the anti-cancer drug MK-1084, the Subject Expert Committee (SEC) functional under the Central...
30 Formulations declared Not of Standard Quality as per data provided by states: CDSCO Drug Alert Dr. Divya Colin24 July 2024 6:00 PM ISTNew Delhi: In line with the 'Not of Standard Quality' data provided by states, the apex drug regulatory body, the Central Drug Standard Control...
Submit complete Phase-I CT report: CDSCO Panel Tells Biological E on Bivalent Typhoid and Paratyphoid A Conjugate Vaccine Dr. Divya Colin23 July 2024 6:00 PM ISTNew Delhi: Reviewing the interim Phase-I clinical trial report of Typhoid and Paratyphoid A Conjugate Vaccine Bivalent, the Subject Expert Committee...
